Indian Pharma industry moving towards formulations

Indian Pharma industry is slowing moving up the value chain. Earlier it used to manufacture active pharmaceutical ingredient at low cost compared to world. Now with competition from China, which provides API at 15-20% low cost, it makes sense to shift focus elsewhere. Many top companies like Lupin, Novartis, Ranbaxy have less revenue stream from API than from formulations. There could also be the reason that formulation business has grown faster than APIs for some companies. API is low scale commodity with low margin. Moreover, with a large number of patent expiries in developed markets like the US and Europe, Indian companies, with skills to develop and manufacture low-cost generic drugs, see a much more lucrative opportunity there than utilising their capacities for manufacturing APIs.
Read More

  • No Image
    Makers Laboratories Ltd

    Makers Laboratories Limited is a rapidly growing Indian Pharmaceutical company with a strong thrust on Branded Generics. Their product portfolio covers a wide range of General H

  • No Image
    Mangalam Drugs Organics Ltd

    Mangalam Drugs & Organics Ltd incorporated in 1972, was promoted by the Dhoot family. Later, MDOL was converted into a public limited company in 2001 and is engaged mainly in ma

  • No Image
    Mangalam Organics Ltd

    Mangalam Organics Ltd formerly known as Dujodwala Products Ltd is engaged in production of camphor, resin and sodium acetate

  • No Image
    Manipal Acunova Ltd

    Manipal Acunova Limited, a contract research organization, provides a range of services to biotechnology, pharmaceutical, device, diagnostic and nutrition, generic drug, and reg

  • No Image
    Mankind Pharma Ltd

    Mankind Pharma, one of the top 5 leading pharmaceutical companies in India, started its journey in 1995.

    It has a vast network includes 50 C&F agents and 7500+ stockist

  • No Image
    Marksans Pharma Ltd

    Marksans Pharma Ltd. is an Indian pharmaceutical company having a global footprint. Their strengths lie in research, manufacturing and marketing of finished dosage pharmaceutic